NEULANDLAB · NSE
Not in active coverage. Cited reporting has mentioned Neuland Laboratories, the record of those mentions is below. Your interest is logged; coverage expands by demand.
Neuland Laboratories has received its highest number of Requests for Proposal in a three-month period in the last few years as global drugmakers look to diversify their supply chains beyond China.
Neuland Laboratories has commissioned the first of four scheduled peptide manufacturing modules at its commercial peptide manufacturing site.
Neuland Laboratories has made its first manufacturing module operational at its commercial peptide manufacturing site.
This page lists where cited reporting has mentioned Neuland Laboratories. It is not the full dossier: developments here are single mentions, not corroborated records. We compile and cite; we do not opine.
New here? The reader's guide explains every page, plate by plate.
fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.